NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle ...
A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. For 21 years, Sebastien Beauzile suffered chronic pain ...
Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...
ROCHESTER, N.Y. – Researchers at Golisano Children’s Hospital have received a multi-million-dollar grant to lead a ...
A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...
Twenty-one-year-old Sebastien Beauzile was all smiles as he was serenaded with “Happy Birthday” on what he calls his new birthday at Cohen Children’s Medical ...
Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.
A Long Island hospital has said that it has successfully eliminated sickle cell disease from Sebastien Beauzile, a 21-year-old from Laurelton, using the groundbreaking Lyfgenia gene therapy. Cohen ...
Researchers studied the efficacy of hydroxyurea at reducing stroke risk in sickle cell anemia, the most common and severe ...
The National Academies of Sciences, Engineering, and Medicine Committee on Sickle ... cell disease (SCD). The committee’s report will: Describe the current healthcare landscape for the management and ...
The incidence of vaso-occlusive episodes and acute chest syndrome in children with sickle cell disease (SCD) is elevated during January to March, a large nationwide, retrospective study in the U.S.